Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals Limited has submitted its financial results for the quarter/half-year ended September 30, 2025, to the NSE. The company has fulfilled its listing obligation by filing these results with the exchange on time. No actual financial figures, revenue numbers, or profit details were provided in the announcement, so the performance cannot be assessed from this filing alone. Shareholders would need to review the full financial results document for specific numbers.
This is a routine regulatory filing with no immediate impact on shareholders or stock price. Investors should look at the actual numbers in the detailed results to gauge the company's Q2/H1 FY26 performance.